Patient-reported outcomes with sofosbuvir and velpatasvir with or without ribavirin for hepatitis C virus-related decompensated cirrhosis: an exploratory analysis from the randomised, open-label ASTRAL-4 phase 3 trial

The Lancet Gastroenterology & Hepatology - Tập 1 - Trang 122-132 - 2016
Zobair M Younossi1,2, Maria Stepanova3, Michael Charlton4, Michael P Curry5, Jacqueline G O'Leary6, Robert S Brown7, Sharon Hunt2
1Center for Liver Diseases, Department of Medicine, Inova Fairfax Hospital, Falls Church, VA, USA
2Betty and Guy Beatty Center for Integrated Research, Inova Health System, Falls Church, VA, USA
3Center for Outcomes Research in Liver Disease, Washington, DC, USA
4Department of Gastroenterology, Intermountain Medical Center, Salt Lake City, UT, USA
5Transplant Institute, Beth Israel Deaconess Medical Center, Boston, MA, USA
6Liver Consultants of Texas, Baylor University Medical Center, Dallas, TX, USA
7Division of Gastroenterology and Hepatology, Weill Cornell Medical College, New York, NY, USA

Tài liệu tham khảo

Thông tin
Thông tin xuất bản

The Lancet Gastroenterology & Hepatology

Tập 1

122-132

Thông tin tác giả